Results 131 to 140 of about 28,620 (235)

Effects of genetic variation at the CYP2C19/CYP2C9 locus on pharmacokinetics of chlorcycloguanil in adult Gambians.

, 2009
AIMS: Antimalarial biguanides are metabolized by CYP2C19, thus genetic variation at the CYP2C locus might affect pharmacokinetics and so treatment outcome for malaria.
Conway, David J, Walton, Robert T., Ann K Miller, Walton, Robert T, Janha, Ramatoulie E, Sam Dunyo, Kirk Rockett, Dunyo, S., David J Conway, Rockett, Kirk, Hannah L Chapman, Paul Milligan, Miller, Ann K, Pirmohamed, M., Archibald Worwui, Opara, H., Rockett, K., Janha, R. E., Robert T Walton, Majidah Hamid-Adiamoh, Miller, A. K., Worwui, A., Worwui, Archibald, Milligan, Paul, Milligan, P., Pirmohamed, Munir, Opara, Hyginus, Sisay-Joof, F., Conway, D. J., Munir Pirmohamed, Peter Winstanley, Hyginus Opara, Winstanley, P., Chapman, Hannah L, Dunyo, Sam, Chapman, H.L., Ramatoulie E Janha, Fatoumatta Sisay-Joof, Winstanley, Peter, Hamid-Adiamoh, M., Sisay-Joof, Fatoumatta, Hamid-Adiamoh, Majidah   +41 more
core   +1 more source

Pharmacokinetic- Pharmacodynamic Analysis of the Role of Cyp2c19 Genotypes in Short-Term Rabeprazole-Based Triple Therapy against Helicobacter Pylori

, 2011
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT center dot Asians have a higher percentage of CYP2C19 poor metabolizers (PMs) and a high percentage of Helicobacter pylori infection compared with Whites.
YANG, JYH-CHIN;YANG, YU-FAN;UANG, YOW-SHIENG;LIN, CHUN-JUNG;WANG, TEH-HONG, 楊智欽;楊喻帆;汪佑襄;林君榮;王德宏   +1 more
core  

CYP2C19 Inhibitor [PDF]

, 2020
openaire   +1 more source

CYP2C19 Inducer [PDF]

, 2020
openaire   +1 more source

Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects

Pharmacogenomics and Personalized Medicine, 2019
Margarita N Dorofeeva,1 Evgenia V Shikh,2 Zhanna M Sizova,1 Alisa V Tarasenko,3 Natalia P Denisenko,4,5 Valeriy V Smirnov,6,7 Kristina A Ryzhikova,4 Zhannet A Sozaeva,4 Elena A Grishina,4 Dmitriy A Sychev5 1Department of Social Expertise, Urgent and ...
Dorofeeva MN, Shikh EV, Sizova ZM, Tarasenko AV, Denisenko NP, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Grishina EA, Sychev DA   +9 more
doaj  

CYP2C19 Gene [PDF]

, 2020
openaire   +1 more source

CYP2C19*2 polymorphism and clopidogrel resistance [PDF]

Archivos de cardiolog�a de M�xico (English ed. Internet), 2021
Beuy, Joob, Viroj, Wiwanitkit
openaire   +2 more sources

Phenotyping of CYP2C19 and CYP3A4 by Using Omeprazole as a Probe Drug and Genotyping of CYP2C19 for Common Allelic Variants in Ethiopians

, 2008
Cytochrome P450 2C19 (CYP2C19) and cytochrome P450 3A4 (CYP3A4) are members of drug metabolizing CYP450 enzymes with documented genetic polymorphism that may cause marked interindividual and interethnic variation in the metabolism and disposition of ...
Gebeyehu, Endalew
core  

Co-Existence of CYP2C19*1/*2 and ABCB1c.3435 CT Genotype has a Potential Impact on Clinical Outcome in CAD Patients Treated with Clopidogrel

Balkan Journal of Medical Genetics
Clopidogrel, is a standard treatment in the prevention of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD).
Nestorovska KA, Naumovska Z, Staninova Stojovska M, Sterjev Z, Dimovski A, Suturkova Lj   +5 more
doaj   +1 more source

FREKUENSI ALEL GEN PEMETABOLISME OBAT CYP2C9*3 DAN CYP2C19*17 PADA POPULASI SUKU BUGIS DI MAKASSAR

, 2011
The cytochrome P450 (CYP450) family enzyme is a primary metabolic pathway for the metabolism of drugs. The two CYP2C subfamilies, these are CYP2C9 and CYP2C19, exhibit wide inter-individual variation in expression which influence the drug metabolism ...
, Theresia Desy Askitosari, , Prof. Dr. Zullies Ikawati, Apt.   +1 more
core